Targeting Myeloid-derived Suppressor Cells and Programmed Death Ligand 1 Confers Therapeutic Advantage of Ablative Hypofractionated Radiation Therapy Compared With Conventional Fractionated Radiation Therapy. [electronic resource]
Producer: 20190320Description: 74-87 p. digitalISSN:- 1879-355X
- Animals
- B7-H1 Antigen -- therapeutic use
- CD8-Positive T-Lymphocytes -- radiation effects
- Carcinoma, Lewis Lung -- immunology
- Combined Modality Therapy -- methods
- Dose Fractionation, Radiation
- Flow Cytometry
- Immunocompetence
- Immunocompromised Host
- Immunotherapy, Adoptive -- methods
- Lymphocytes, Tumor-Infiltrating -- radiation effects
- Melanoma, Experimental -- immunology
- Mice
- Mice, Inbred BALB C
- Mice, Inbred C57BL
- Mice, Nude
- Myeloid-Derived Suppressor Cells -- cytology
- Programmed Cell Death 1 Receptor -- antagonists & inhibitors
- Radiation Dose Hypofractionation
- Random Allocation
- Receptors, Vascular Endothelial Growth Factor -- antagonists & inhibitors
- Relative Biological Effectiveness
- Tumor Burden -- radiation effects
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.